Chubby Cheeks: Causes and Facial Slimming Options in Toronto & Markham

1. Swelling (Belkyra 5–14 days post-treatment, common but manageable); 2. Bruising (injection-related, resolving within 1–2 weeks); 3. Asymmetry (can be minimized through precise technique and staged treatments); 4. Volume loss / hollowing (this is a particular concern for Asian faces; Dr. Xu’s protocol mitigates this risk through low-dose, precision injection techniques); 5. Transient nerve involvement (rare, mostly temporary); 6. Reduced chewing strength (masseter over-relaxation with neuromodulator, rare); 7. Results fall short of expectations (clients in whom bone structure is the primary contributing factor require particularly careful expectation management).

Pregnancy, breastfeeding, active autoimmune flare, coagulation disorder, active facial infection, known allergy to deoxycholic acid or neuromodulators, incomplete recovery from facial surgery within the past 6 months, unassessed severe keloid tendency, significant ongoing weight fluctuation, or unrealistic expectations (believing a single session can achieve a V-line result) — in any of these situations, Dr. Xu will recommend postponing treatment or addressing the underlying issue first.

Five core principles: (1) Always perform the four-factor differential to rule out bone structure or puffiness as the primary driver; (2) start at the lower end of the dosage range and reassess before incrementally increasing; (3) allow a minimum of 4 weeks between sessions to ensure swelling has fully resolved before re-evaluation; (4) avoid significant weight loss immediately before or after treatment; (5) apply cold compresses and follow anti-inflammatory aftercare post-procedure — book a follow-up immediately if any persistent discomfort occurs.

Every client signs an informed consent form before their first treatment. It covers: how the treatment works, possible adverse reactions and their likelihood, alternative options, criteria for stopping treatment, follow-up scheduling, and an optional Media Release. Dr. Xu personally walks through every item with you — this is never delegated to administrative staff.

It depends on the primary contributing factor. If the fullness is caused by true buccal fat excess, Belkyra precisely dissolves and permanently clears the fat cells, and results are generally long-lasting — unless there is significant weight fluctuation. If the cause is masseter hypertrophy, neuromodulator treatment requires maintenance every 6 months. If it is the sagging-laxity type, Ultherapy® requires maintenance every 12–18 months. If the roundness is determined by bone structure, no soft-tissue treatment can alter the underlying skeletal shape — in these cases, Dr. Xu will recommend embracing the overall facial form rather than pursuing localized volume reduction.

All three are anatomically distinct and require different treatment approaches. Chubby cheeks primarily refers to fullness of the buccal fat pad in the lower cheek (anterior to the masseter) — soft and mobile on palpation. Belkyra® is the preferred treatment. Masseter hypertrophy refers to thickening of the muscle at the jaw angle, which hardens and bulges visibly when biting down. Neuromodulator (Botox®) is the preferred treatment. Double chin — if the concern is submental fat accumulation, the preferred approach is Belkyra submental treatment combined with CoolSculpting Mini. All three conditions can coexist and are commonly addressed with a combination plan — however, a physical palpation assessment must be performed before any device or treatment is selected.

Belkyra is safe on Asian faces; however, Asian-specialist dosing protocols are essential. Dr. Xu's protocol: single-session dosage 0.4–0.8 ml (North American standard: 1.0–2.0 ml), carefully selected points rather than dense coverage, with 4–6 week intervals. Asian faces have limited facial fat and little margin for error — over-dissolving can cause irreversible volume loss / hollowing. As an Allergan North America Trainer whose clientele is 90% Asian, Dr. Xu's protocol comes from real clinical adjustment.

The three most common causes of treatment failure: (1) Injecting without differential assessment — treating masseter hypertrophy or tissue laxity as if it were excess fat — dissolving what little fat was there and creating hollowing; (2) Applying North American Caucasian dosing templates without adjustment — Asian faces carry less facial fat to begin with, so the same dosage effectively becomes an overdose; (3) Not performed by a physician — the facial nerve branches, parotid duct, and facial artery are densely distributed in this region — performing injections without a physician significantly increases the risk of serious complications.

It depends on the primary contributing factor: True fat type: 2–4 sessions (once every 4–6 weeks); Masseter type: 1 session (maintenance every 6 months); Laxity type: 1 session of Ultherapy® (maintenance every 12–18 months); Mixed type: 2–3 stage combination plan. When Belkyra is performed alongside Ultherapy®, a 2–4 week interval is recommended to prevent overlapping swelling from compromising outcome assessment.

No. Pregnancy and breastfeeding are absolute contraindications for all injectable aesthetic treatments — including Belkyra®, neuromodulators, and dermal fillers. During periods of hormonal fluctuation, facial tissue edema and metabolic changes make accurate outcome assessment unreliable. We recommend waiting — post-partum, at least 3 months after complete weaning, and once weight has stabilized — before beginning the formal assessment. If there is an urgent concern during this phase, lifestyle modifications and lymphatic drainage are recommended as a first step.

Belkyra fat-dissolving injection (injectable deoxycholic acid): minimally invasive, targeted, suitable for small facial areas, typically requiring 2–4 sessions. Facial liposuction (surgical): more invasive, longer recovery, and carries a higher risk of facial nerve injury when applied to the face. This procedure is not offered at Dr. Xu's clinic. CoolSculpting: non-invasive, no needles, minimal downtime, with dedicated facial applicators — ideal for clients who prefer to avoid injections. The choice among all three options is guided by physical assessment, fat layer thickness, and your lifestyle.

You may apply makeup 24 hours after Belkyra® injections, though noticeable swelling is expected during the first week — we recommend scheduling your appointment on a weekend or around a holiday. CoolSculpting® allows you to resume normal activities the same day. Botox® masseter injections have minimal downtime. After Ultherapy®, makeup can be applied immediately, with mild achiness possible during the first week. General post-care guidelines: (1) Schedule Belkyra® on a weekend; (2) Avoid strenuous exercise and saunas for 48 hours post-treatment; (3) Avoid facial massage for 1 week post-treatment.

Pricing reflects who assesses you, who identifies the primary cause, and who performs the treatment — not the device or product alone. Facial slimming involves four distinct clinical mechanisms, leaves very little room for error, and carries the risk of irreversible volume loss. Dr. Xu is personally and deeply involved in these cases, and the pricing structure reflects that level of medical expertise. The right treatment plan is determined by your clinical findings, not your budget. Every first-time client receives a complimentary 30-minute consultation and assessment; a personalized plan will be discussed after the four-factor evaluation.

ID Cosmetic Clinic is located at 30 Gibson Dr., Markham — approximately 30–40 minutes by car from downtown Toronto, 20–25 minutes from North York, 15–20 minutes from Richmond Hill / Vaughan, and 20–30 minutes from Scarborough. Conveniently situated near the intersection of Highway 7 and Highways 404 / 407. Facial contouring has very little margin for error, and hollowing is irreversible. Choosing the right physician matters far more than proximity. The cost of correcting a poorly performed treatment — if correction is even possible — far outweighs the inconvenience of a single commute.

No. The primary causes of cheek fullness are buccal fat pad volume / masseter hypertrophy / bone structure / SMAS laxity; none of these structures change significantly with overall body fat percentage. Clinically, many slender Asian women (BMI 19–22) still present with a noticeably full lower face — because this is a structural issue, not a weight issue. Attempting to slim the face through weight loss alone often comes at the cost of mid-face hollowing + accelerated aging appearance.

Belkyra (deoxycholic acid) is a fat-dissolving injectable approved by both Health Canada and the FDA. Its mechanism of action permanently disrupts the fat cell membrane; treated fat cells do not regenerate. Therefore, there is no rebound (unless significant weight gain causes the remaining fat cells to expand). Safety depends on: (1) the physician personally performing the injections to avoid the marginal mandibular branch of the facial nerve; (2) using a low-dose, multi-point dispersal protocol; and (3) strict candidate screening to exclude patients with aging-related skin laxity.

These three are structurally distinct: Fat — soft and pinchable; moves upward when smiling; Masseter — a firm mass becomes prominent when clenching (place your fingers along the jaw angle and clench to feel it); Bone structure — firm, non-movable. Clinically, 35% of Asian women who believe their facial fullness is due to excess fat are actually presenting with masseter hypertrophy — in which case Belkyra® is entirely ineffective. Botox® masseter injections must be addressed first.

After 35 years of age, mid-face fat compartments begin to descend, forming “pseudo-fat accumulation” (jowl). What appears to be a progressively “larger” face is actually “fat displacement + skin laxity”. In this situation, indiscriminate fat dissolving will only deepen mid-face hollowing and further loosen the jawline, resulting in an accelerated aging appearance. The appropriate approach is Sofwave™ / Ultherapy® lifting combined with minimal mid-face repositioning filler.

It depends on structural classification: Buccal fat pad type: 2–3 sessions (once every 6 weeks); Mandibular fat type: 1–2 sessions; Submental / double chin: 2–4 sessions (CoolMini can be used as an alternative to reduce the number of injection sessions). Results from each treatment emerge gradually over 6–12 weeks — visible slimming is not immediate. Attempting to rush the process with a single high-dose session significantly increases the risk of contour depression and nerve injury.